Genetic and clinical study of myeloperoxidase's association with coronary artery disease

Lina N Adam1, Omar A M Al-Habib2, Ashur Y Oraha3

  • 1Department of Biology, College of Science, University of Zakho, Duhok, Kurdistan Region, Iraq. lina.adam@uoz.edu.krd.

Summary

Serum myeloperoxidase (MPO) levels show no significant difference in coronary artery disease (CAD) patients. However, mean platelet volume (MPV) and red cell distribution width (RDW%) may predict atherosclerosis severity in CAD.